Element Science, Inc.
Element Science is a San Francisco-based medical device and digital health company focused on developing life-saving wearable solutions to address the needs of high-risk cardiovascular patients. Their mission is to create a safer, healthier world by developing a next-generation wearable digital platform that combines human-centric engineering, sophisticated machine learning, and rigorous medical device standards to reduce death and hospitalization from heart disease. Their flagship product, Jewel®, is a revolutionary patch wearable cardioverter defibrillator offering 24/7 protection in a sleek, comfortable design. The company has secured FDA approval for Jewel® and it is currently commercially available in limited U.S. markets. Element Science was founded in 2011 by Uday Kumar, MD, who also founded iRhythm Technologies.
Element Science, Inc.
Element Science is a San Francisco-based medical device and digital health company focused on developing life-saving wearable solutions to address the needs of high-risk cardiovascular patients. Their mission is to create a safer, healthier world by developing a next-generation wearable digital platform that combines human-centric engineering, sophisticated machine learning, and rigorous medical device standards to reduce death and hospitalization from heart disease. Their flagship product, Jewel®, is a revolutionary patch wearable cardioverter defibrillator offering 24/7 protection in a sleek, comfortable design. The company has secured FDA approval for Jewel® and it is currently commercially available in limited U.S. markets. Element Science was founded in 2011 by Uday Kumar, MD, who also founded iRhythm Technologies.
TL;DR
Headquarters: San Francisco, CA
Founded: 2011
Flagship product: Jewel® patch wearable cardioverter defibrillator
Regulatory status: FDA approval (commercially available in limited U.S. markets); CE/UKCA marking reported
Total funding (reported): USD 183,100,000
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Sudden cardiac arrest and high‑risk cardiovascular patient monitoring and protection.
Founded
2011
Industry
Medical Equipment Manufacturing
Tech Stack
Funding Track Record
Most recent announced round (Mar 3, 2020); multiple investors reported
Investor Signal
“Participation from institutional life‑science and venture investors including Deerfield, Qiming Venture Partners (and Qiming US), Cormorant Asset Management, Third Rock Ventures, Invus, Google Ventures, Prospect Venture Partners”